Tofacitinib in antisynthetase syndrome-related rapidly progressive interstitial lung disease - Sorbonne Université
Journal Articles Rheumatology Year : 2020

Tofacitinib in antisynthetase syndrome-related rapidly progressive interstitial lung disease

Domains

Life Sciences [q-bio]

Gestionnaire HAL 4 Sorbonne Université  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03104606

Submitted on : Saturday, January 9, 2021-1:46:31 PM

Last modification on : Thursday, December 14, 2023-1:50:37 PM

No file

Dates and versions

hal-03104606 , version 1 (09-01-2021)

Identifiers

Cite

Marc Pineton de Chambrun, Baptiste Hervier, Simon Chauveau, Yacine Tandjaoui-Lambiotte, Alain Combes, et al.. Tofacitinib in antisynthetase syndrome-related rapidly progressive interstitial lung disease. Rheumatology, 2020, 59 (12), pp.e142-e143. ⟨10.1093/rheumatology/keaa323⟩. ⟨hal-03104606⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-PARIS13 ICAN USPC SORBONNE-UNIVERSITE SU-MEDECINE SORBONNE-PARIS-NORD IHU_ICAN
21 View
0 Download

Altmetric

Share

More